About Beth Seidenberg
Form D filings for Arsenal Biosciences from 2022 to 2024 list Beth Seidenberg as director.
Beth Seidenberg first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Beth Seidenberg in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Beth Seidenberg works with at each company, as listed on that company's latest Form D.
Arsenal Biosciences, Inc. · Form D, Sep 4, 2024
MF
Matthew Fust
Director
VB
Valentin Barsan
Director
SP
Sean Parker
Director
BB
Brook Byers
Director
JA
James Ahlers
Executive officer
KD
Kenneth Drazan
Executive officer and director
IP
Irene Pleasure
Secretary